2026-06-14T00:34:17Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/141582025-04-04T09:14:15Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19608
Repisalud
author
Staadegaard, Lisa
author
Caini, Saverio
author
Wangchuk, Sonam
author
Thapa, Binay
author
Ferreira de Almeida, Walquiria Aparecida
author
Cotrim de Carvalho, Felipe
author
Njouom, Richard
author
Fasce, Rodrigo A
author
Bustos, Patricia
author
Kyncl, Jan
author
Novakova, Ludmila
author
Caicedo, Alfredo Bruno
author
de Mora Coloma, Domenica Joseth
author
Meijer, Adam
author
Hooiveld, Mariëtte
author
Huang, Sue
author
Wood, Tim
author
Guiomar, Raquel
author
Rodrigues, Ana Paula
author
Danilenko, Daria
author
Stolyarov, Kirill
author
Lee, Vernon Jian Ming
author
Ang, Li Wei
author
Cohen, Cheryl
author
Moyes, Jocelyn
author
Larrauri, Amparo
author
Delgado-Sanz, Concepcion
author
Le, Mai Quynh
author
Hoang, Phuong Vu Mai
author
Demont, Clarisse
author
Bangert, Mathieu
author
van Summeren, Jojanneke
author
Dückers, Michel
author
Paget, John
funder
AstraZeneca
funder
Sanofi
2022-04-22T15:15:36Z
2022-04-22T15:15:36Z
2021-07
Open Forum Infect Dis. 2021;8(7):ofab159.
10.1093/ofid/ofab159
2328-8957
Open Forum Infectious Diseases
34337092
http://hdl.handle.net/20.500.12105/14158
Background: Respiratory syncytial virus (RSV) is one of the leading causes of acute respiratory tract infections. To optimize control strategies, a better understanding of the global epidemiology of RSV is critical. To this end, we initiated the Global Epidemiology of RSV in Hospitalized and Community care study (GERi). Methods: Focal points from 44 countries were approached to join GERi and share detailed RSV surveillance data. Countries completed a questionnaire on the characteristics of their surveillance system. Results: Fifteen countries provided granular surveillance data and information on their surveillance system. A median (interquartile range) of 1641 (552-2415) RSV cases per season were reported from 2000 and 2020. The majority (55%) of RSV cases occurred in the <1-year-olds, with 8% of cases reported in those aged ≥65 years. Hospitalized cases were younger than those in community care. We found no age difference between RSV subtypes and no clear pattern of dominant subtypes. Conclusions: The high number of cases in the <1-year-olds indicates a need to focus prevention efforts in this group. The minimal differences between RSV subtypes and their co-circulation implies that prevention needs to target both subtypes. Importantly, there appears to be a lack of RSV surveillance data in the elderly.
eng
Surveillance
RSV: respiratory infections
Epidemiology
The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 Countries
research article
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
URL
https://repisalud.isciii.es/bitstreams/b5996ed8-9c55-4fb2-9f50-2672dceba33d/download
File
MD5
f1ec9e0a8cb83af857e0b8550bd23873
413331
application/pdf
TheGlobalEpidemiologyOf_2021.pdf
URL
https://repisalud.isciii.es/bitstreams/2d805cef-9489-4503-a6ef-4c2c849d7de8/download
File
MD5
47011ca7c25f482e4c9dc56aae067fab
396698
image/jpeg
TheGlobalEpidemiologyOfSuplementtary1_2021.jpeg
URL
https://repisalud.isciii.es/bitstreams/6d21e84d-2b26-43cb-b7de-560288880b63/download
File
MD5
64e8f6bcb558200a664382dd0adc186e
1108023
image/jpeg
TheGlobalEpidemiologyOfSuplementtary2_2021.jpeg
URL
https://repisalud.isciii.es/bitstreams/c191232f-ed22-4222-9f4c-84198fca1cff/download
File
MD5
ae52c682b71f6f27e8246f6fe46779ac
475275
image/jpeg
TheGlobalEpidemiologyOfSuplementtary3_2021.jpeg
URL
https://repisalud.isciii.es/bitstreams/ae9a6b71-e413-417d-879a-51e43c069a4b/download
File
MD5
1ae86a26c58d5160661a6de978fb806a
3125494
image/jpeg
TheGlobalEpidemiologyOfSuplementtary4_2021.jpeg
URL
https://repisalud.isciii.es/bitstreams/1657ea90-f1d7-4531-a827-92563aa3d9de/download
File
MD5
bd8a8104dcbb085b6bd435ba7c3ff6f1
2974255
image/jpeg
TheGlobalEpidemiologyOfSuplementtary5_2021.jpeg
URL
https://repisalud.isciii.es/bitstreams/067dde5b-d355-43be-a3f7-d2a33b844380/download
File
MD5
ae52c682b71f6f27e8246f6fe46779ac
475275
image/jpeg
TheGlobalEpidemiologyOfSuplementtary6_2021.jpeg
URL
https://repisalud.isciii.es/bitstreams/7629e049-2a37-4d28-8d64-6fe1602d4fc7/download
File
MD5
02669c0d487394ae0044ce6401dc0af0
411105
image/jpeg
TheGlobalEpidemiologyOfSuplementtary7_2021.jpeg
URL
https://repisalud.isciii.es/bitstreams/acc53314-b641-4231-9733-c77636830126/download
File
MD5
4effc3a59c114dfa46e47a6af594cd36
71647
application/vnd.openxmlformats-officedocument.wordprocessingml.document
TheGlobalEpidemiologyOfSuplementtaryMaterials_2021.docx
URL
https://repisalud.isciii.es/bitstreams/c5c8ec89-83d8-4bdf-85c9-5d05ce05688b/download
File
MD5
59fdf9cdff65715c98a643c5c2b41b06
52787
text/plain
TheGlobalEpidemiologyOf_2021.pdf.txt
URL
https://repisalud.isciii.es/bitstreams/75bd6ebc-8fda-40f5-9db4-2103a37e6f1a/download
File
MD5
584e8a559f2d61986b858ba807a1c4fd
6069
text/plain
TheGlobalEpidemiologyOfSuplementtaryMaterials_2021.docx.txt